SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014075
Filing Date
2024-04-09
Accepted
2024-04-09 16:27:34
Documents
14
Period of Report
2024-04-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43885
2 ex99-1.htm EX-99.1 57503
  Complete submission text file 0001493152-24-014075.txt   289849

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nrxs-20240404.xsd EX-101.SCH 3015
4 XBRL LABEL FILE nrxs-20240404_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE nrxs-20240404_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3762
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 24833057
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)